News Release

Young, healthy people still vulnerable to CVD if their LDL cholesterol is high

Circulation Journal Report

Peer-Reviewed Publication

American Heart Association

DALLAS, August 20, 2018 -- Young, healthy people may still face a lifetime risk of premature death from cardiovascular disease if they cannot keep their cholesterol levels in check, according to new observational research in the American Heart Association's journal Circulation.

Researchers in this latest study looked at associations between low-density lipoprotein-cholesterol (LDL-C) and non-high-density lipoprotein-cholesterol (HDL-C) thresholds and cardiovascular disease (CVD) and coronary heart disease (CHD) mortality to evaluate whether people believed to be at low 10-year risk for heart health problems should begin pursuing efforts to lower elevated cholesterol earlier through lifestyle changes, and in some cases, cholesterol-lowering medication.

Coronary heart disease remains the leading cause of death in the United States, affecting half of all men and one-third of all women. An estimated 28.5 million Americans have total cholesterol levels of 240 mg/dL or higher. LDL is a type of cholesterol that contributes to clogged arteries which increases the risk of heart attack and stroke.

"High cholesterol at younger ages means there will be a greater burden of cardiovascular disease as these individuals age. This research highlights the need to educate Americans of any age on the risks of elevated cholesterol, and ways to keep cholesterol at a healthy level throughout life," said Robert Eckel, M.D., past president of the American Heart Association and Director of the Lipid Clinic at University of Colorado Hospital in Aurora. Eckel has been active in developing the AHA's Check.Change.Control.Cholesterol™ initiative to help providers and patients work together to identify cardiovascular health risks.

Clinical trials typically have focused on individuals at moderate or high risk for cardiovascular disease. This observational study included 36,375 young, relatively healthy participants of the Cooper Center Longitudinal Study who were free of diabetes or cardiovascular disease and were followed for 27 years. For a low-risk person, researchers discovered that LDL levels were independently associated with increased chances of dying from cardiovascular disease. Without taking into account other risk factors, researchers' other findings included:

  • Compared with participants who had LDL readings of under 100 mg/dL, those with LDL levels in the range of 100-159 mg/dL had a 30 to 40 percent higher risk of cardiovascular disease death.
  • Those with LDL levels of 160 mg/dL or higher had a 70 to 90 percent increased risk of cardiovascular death, compared with participants who had LDL readings of under 100 mg/dL.
  • Among the group (72 percent men, average age 42), there were 1,086 deaths from cardiovascular disease, such as stroke, and 598 coronary heart disease deaths.

"Our study demonstrates that having a low 10-year estimated cardiovascular disease risk does not eliminate the risk posed by elevated LDL over the course of a lifetime," said lead study author Shuaib Abdullah, M.D., at University of Texas Southwestern Medical Center and Veteran's Affairs North Texas Healthcare System in Dallas, Texas. The study was done in collaboration with investigators from the Cooper Institute. "Those with low risk should pursue lifestyle interventions, such as diet and exercise, to achieve LDLs levels as low as possible, preferably under 100 mg/dL. Limiting saturated fat intake, maintaining a healthy weight, discontinuing tobacco use, and increasing aerobic exercise should apply to everyone."

###

Co-authors: Shuaib M. Abdullah, M.D., MSCs; Laura F. Defina, M.D.; David Leonard, Ph.D.; Carolyn E. Barlow, Ph.D.; Nina B. Radford, M.D.; Benjamin L. Willis, M.D., M.P.H.; Anand Rohatgi, M.D., MSCs; Darren K. McGuire, M.D., M.H.Sc; James A. de Lemos, M.D.; Scott M. Grundy, M.D., Ph.D.; Jarett D. Berry, M.D., M.S.; and Amit Khera, M.D., M.Sc. Author disclosures are on the manuscript.

The Cooper Institute funded the study.

Additional Resources:

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at http://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is devoted to saving people from heart disease and stroke - the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation's oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.